Healthcare Magazine October 2018 | Page 38

TECHNOLOGY
38

COULD THE SCREENING PROCESS FOR CARDIAC DRUG APPROVAL BE SET TO CHANGE FOREVER ?

Biotechnology company Novoheart believes it can ‘ revolutionise ’ the flawed process for screening new drugs . Healthcare Global speaks to CSO Kevin Costa to find out more

WRITTEN BY STUART HODGE
OCTOBER 2018